Log in to save to my catalogue

Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chr...

Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2618503348

Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chronic kidney disease

About this item

Full title

Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chronic kidney disease

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European radiology, 2022-04, Vol.32 (4), p.2564-2571

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
To assess the feasibility of direct intra-lymphatic administration of diluted ferumoxytol as a T1-positive contrast agent for dynamic contrast-enhanced MR lymphangiography (DCMRL) imaging of the central lymphatics in children with renal disease.
Methods
In vitro scan of dilute ferumoxytol was initially performed using time-resolved...

Alternative Titles

Full title

Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chronic kidney disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2618503348

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2618503348

Other Identifiers

ISSN

0938-7994

E-ISSN

1432-1084

DOI

10.1007/s00330-021-08448-x

How to access this item